BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10809390)

  • 21. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
    Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
    Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.
    Soares M; Hanisch FG; Finn OJ; Ciborowski P
    Protein Expr Purif; 2001 Jun; 22(1):92-100. PubMed ID: 11388805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
    Blanchfield JT; Dutton JL; Hogg RC; Gallagher OP; Craik DJ; Jones A; Adams DJ; Lewis RJ; Alewood PF; Toth I
    J Med Chem; 2003 Mar; 46(7):1266-72. PubMed ID: 12646037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced microwave-assisted method for on-bead disulfide bond formation: synthesis of alpha-conotoxin MII.
    Galanis AS; Albericio F; Grøtli M
    Biopolymers; 2009; 92(1):23-34. PubMed ID: 19003899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
    Petrakou E; Murray A; Rosamund C; Graves L; Price MR
    Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a MUC1-based cancer vaccine.
    Hanisch FG
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies.
    Smorodinsky N; Weiss M; Hartmann ML; Baruch A; Harness E; Yaakobovitz M; Keydar I; Wreschner DH
    Biochem Biophys Res Commun; 1996 Nov; 228(1):115-21. PubMed ID: 8912645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J; Allard WJ; Davis G; Yeung KK
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propeptide does not act as an intramolecular chaperone but facilitates protein disulfide isomerase-assisted folding of a conotoxin precursor.
    Buczek O; Olivera BM; Bulaj G
    Biochemistry; 2004 Feb; 43(4):1093-101. PubMed ID: 14744155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total chemical synthesis and oxidative folding of delta-conotoxin PVIA containing an N-terminal propeptide.
    Buczek P; Buczek O; Bulaj G
    Biopolymers; 2005; 80(1):50-7. PubMed ID: 15641120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antibody recognition of cyclic epitope peptides, together with their dimer and conjugated derivatives based on residues 9-22 of herpes simplex virus type 1 glycoprotein D.
    Jakab A; Schlosser G; Feijlbrief M; Welling-Wester S; Manea M; Vila-Perello M; Andreu D; Hudecz F; Mezo G
    Bioconjug Chem; 2009 Apr; 20(4):683-92. PubMed ID: 19271736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, solution conformation, and antibody recognition of oligotuftsin-based conjugates containing a beta-amyloid(4-10) plaque-specific epitope.
    Manea M; Hudecz F; Przybylski M; Mezõ G
    Bioconjug Chem; 2005; 16(4):921-8. PubMed ID: 16029033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel conotoxin framework with a helix-loop-helix (Cs alpha/alpha) fold.
    Möller C; Rahmankhah S; Lauer-Fields J; Bubis J; Fields GB; Marí F
    Biochemistry; 2005 Dec; 44(49):15986-96. PubMed ID: 16331958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.
    Ruchala P; Varadi G; Ishino T; Scibek J; Bhattacharya M; Urbina C; Ryk DV; Uings I; Chaiken I
    Biopolymers; 2004 Apr; 73(5):556-68. PubMed ID: 15048779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heteroclitic recognition of combinatorial TX1TX2T peptide mixtures by mucin-2 protein specific monoclonal antibody.
    Windberg E; Uray K; Illyés E; Skribanek Z; Price MR; Sebestyén F; Hudecz F
    J Pept Sci; 2004 Jan; 10(1):56-65. PubMed ID: 14959892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
    Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
    Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
    Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.